上市公司再掀“回購潮” 行業龍頭領銜提信心
格隆匯9月15日丨市場持續震盪之下,一批上市公司選擇回購股份以提振市場情緒、傳遞發展信心。據統計,2022年8月以來,已有38家A股上市公司披露了股票回購預案(剔除股權激勵回購),其中不乏各細分行業中的龍頭企業。從回購金額來看,本輪迴購金額前三名分別爲中國石化、榮盛石化和廣匯能源,其中中國石化的回購金額上限達到25億元。從行業來看,醫藥生物行業成爲本輪迴購最積極的行業。從進展來看,目前已有半數以上的公司實施了回購,其中2家公司已超額完成回購目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.